{
	"type": "rich",
	"version": "1.0",
	"provider_name": "Action Network",
	"provider_url": "https://actionnetwork.org",
	
	"html": "<link href='https://actionnetwork.org/css/style-embed-v3.css' rel='stylesheet' type='text/css' /><script src='https://actionnetwork.org/widgets/v6/letter/federal-facilitate-medical-marijuana-research?format=js&source=widget'></script><div id='can-letter-area-federal-facilitate-medical-marijuana-research' style='width: 100%'><!-- this div is the target for our HTML insertion --></div>",
	"author_name": "NORML",
	"author_url": "https://actionnetwork.org/groups/norml",
	"title": "Federal: Facilitate Medical Marijuana Research",
	"thumbnail_url": "https://can2-prod.s3.amazonaws.com/letters/photos/000/040/673/normal/take_action_image.jpeg",
	"description": "Representatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017. The Act amends federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products. Despite the fact that over 200 million Americans now have legal access to some form of medical marijuana, present regulations make clinical investigations involving cannabis needlessly onerous. Passage of this measure would expedite federal reviews of clinical protocols, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science. Please contact your Representative and urge him/her to support this important measure.",
	"url": "http://norml.org/action-center/item/federal-facilitate-medical-marijuana-research"
}